Latest News

Date Title Topic
09 Sep 2017 ESMO 2017: Webcasts
09 Sep 2017 ESMO 2017: Daily Broadcasts
09 Sep 2017 ESMO 2017 Media Alert: Hot Topic at ESMO 2017: Session Focuses on Adjuvant Chemotherapy Duration in Colon Cancer
09 Sep 2017 ESMO 2017 Press Release: Durvalumab Improves Progression-free Survival in Stage III Lung Cancer Lung and other thoracic tumours
09 Sep 2017 ESMO 2017 Press Release: Patients Feel Psycho-social Impact of Chemo More Acutely Than Physical Side Effects
09 Sep 2017 ESMO 2017 Press Release: Osimertinib Improves Progression-free Survival in Patients with EGFR Mutated Lung Cancer Lung and other thoracic tumours
09 Sep 2017 ESMO 2017 Press Release: “Triggers”: a New Tool to Assess Cancer Patients’ Palliative Needs Palliative and supportive care
09 Sep 2017 ESMO 2017 Press Release: Study Identifies Factors that Limit Work Ability of Young Adult Cancer Survivors
Webcasts
08 Sep 2017 ESMO 2017: Rucaparib Shows Clinical Benefit as Maintenance Therapy in Patients with Recurrent Ovarian Cancer Gynaecologic malignancies - Anticancer agents & Biologic therapy
08 Sep 2017 ESMO 2017: Adding Abiraterone Acetate or Docetaxel Plus Prednisone to Standard of Care in Patients with High-Risk Prostate Cancer Genitourinary cancers - Anticancer agents & Biologic therapy
08 Sep 2017 ESMO 2017: Invasive DFS Rates Following Trastuzumab are Improved with Neratinib Over Placebo in Early Stage HER2-positive Breast Cancer Breast cancer - Anticancer agents & Biologic therapy
08 Sep 2017 ESMO 2017: Pembrolizumab Demonstrates Antitumour Activity in Advanced Gastric Cancer as Monotherapy and Combined with Chemotherapy Gastrointestinal cancers - Anticancer agents & Biologic therapy
08 Sep 2017 ESMO 2017: Combined Taselisib and Letrozole Improves Response in Postmenopausal Women with ER-positive, HER-negative Early Breast Cancer Breast cancer - Anticancer agents & Biologic therapy